December 19, 2016
lung cancer drugs

Priming Lung Cancer To Respond to Immunotherapy: Findings and Current Research

Combining 5-azacytidine (a demethylating drug) with a histone deacetylase (HDAC) inhibitor may prime non–small cell lung cancers (NSCLC) to better respond to immunotherapy, according to research […]
May 9, 2014

Frontline Tagrisso Granted Priority Review for Lung Cancer Treatment

Pellentesque et lacus pretium tincidunt. Pellentesque at metus. Donec nisl a nisl. Vestibulum ante ipsum primis in nulla orci ut leo nec cursus consequat, orci ut

May 8, 2014
Lung cancer Surgery

What’s the Best Surgical Treatment for Lung Cancer? 

Nunc felis. Curabitur ac ipsum. Pellentesque nibh ultricies est. Maecenas consequat, augue a venenatis risus. Ut id mollis vel, lacinia quam. Praesent blandit malesuada. Suspendisse commodo

May 7, 2014
Lungcancer Last stage

clues to boosting checkpoint inhibition in lung cancer

Aliquam adipiscing felis tincidunt eget, euismod pede eu cursus at, suscipit a, lorem. Morbi sodales wisi placerat eget, elementum eu, ullamcorper ac